Authors: ZENK J WALDFAHRER F PETSCH S IRO H

Citation: J. Zenk et al., LONG-TERM PERCUTANEOUS ENDOSCOPIC GASTROSTOMY AND TUMORS OF THE UPPERAERODIGESTIVE TRACT, HNO. Hals-, Nasen-, Ohrenarzte, 46(7), 1998, pp. 660-665

Authors: LOEFFLER M DIEHL V PFREUNDSCHUH M RUHL U HASENCLEVER D NISTERSBACKES H SIEBER M TESCH H FRANKLIN J GEILEN W BARTELS H CARTONI C DOLKEN G ENZIAN J FUCHS R GASSMANN W GERHARTZ H HAGENAUKAMP U HILLER E HINKELBEIN H HINTERBERGER W KIRCHNER H KOCH P KRUGER B KURTEN H KUTZNER K LOOS U MENDE W MULLER H OERTEL W PETSCH S PFAB R PFLUGER H ROHLOFF R SAUER R SCHALK K SCHICK HD SCHOPPE W SZEPESI S TEICHMANN J WORST P FISCHER R GEORGII A HUBNER K SCHWARZE EW

Citation: M. Loeffler et al., DOSE-RESPONSE RELATIONSHIP OF COMPLEMENTARY RADIOTHERAPY FOLLOWING 4 CYCLES OF COMBINATION CHEMOTHERAPY IN INTERMEDIATE-STAGE HODGKINS-DISEASE, Journal of clinical oncology, 15(6), 1997, pp. 2275-2287

Authors: FISLER DK MACKWELL SJ PETSCH S

Citation: Dk. Fisler et al., GRAIN-BOUNDARY DIFFUSION IN ENSTATITE, Physics and chemistry of minerals, 24(4), 1997, pp. 264-273

Authors: DIEHL V LOEFFLER M PFREUNDSCHUH M RUEHL U HASENCLEVER D NISTERSBACKES H SIEBER M SMITH K TESCH H GEILEN W ADLER M BARTELS H BRANDENBURG U DIEZLER P DOELKEN G ENZIAN J FUCHS R GASSMANN W GERHARTZ H HAGENAUKAMP U HECHT T HILLER E HINKELBEIN H LATHAN B KIRCHNER H KUEHN G KUERTEN H LOOS U MAKOSKI B OERTEL W PETSCH S PFAB R PFLUEGER H PLANKER M ROHLOFF R SACK H SAMANDARI S SAUER R SCHALK K SCHMITZ G SCHOPPE W SCHWIEDER G SZEPESI S TEICHMANN J WILHELMY W WORST P FISCHER R GEORGII A HUEBNER K SCHWARZE EW

Citation: V. Diehl et al., FURTHER CHEMOTHERAPY VERSUS LOW-DOSE INVOLVED-FIELD RADIOTHERAPY AS CONSOLIDATION OF COMPLETE REMISSION AFTER 6 CYCLES OF ALTERNATING CHEMOTHERAPY IN PATIENTS WITH ADVANCED HODGKINS-DISEASE, Annals of oncology, 6(9), 1995, pp. 901-910

Authors: FUCHS R LOFFLER M PFREUNDSCHUH M DOLKEN G GERHARTZ H HAGENAUKAMP U HILLER E PETSCH S PFLUGER KH RUHL U SMITH K TEICHMANN K DIEHL V

Citation: R. Fuchs et al., PROGNOSIS OF HIGH-DOSE CHEMOTHERAPY AUTOLOGOUS BONE-MARROW TRANSPLANTATION CANDIDATES NOT RECEIVING THIS TREATMENT AFTER FAILURE OF PRIMARYTHERAPY OF HODGKINS-DISEASE, Leukemia & lymphoma, 14(1-2), 1994, pp. 79-89